comparemela.com

Latest Breaking News On - Intravenous drug - Page 1 : comparemela.com

Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won t bleed this unique species dry

Horseshoe crabs in spawning season at Reeds Beach, N.J., on June 13, 2023. AP Photo/Matt RourkeIf you have ever gotten a vaccine or received an intravenous drug and did not come down with a potentially life-threatening fever, you can thank a horseshoe crab (Limulus polyphemus). How can animals that are often called living fossils, because they have barely changed over millions of years, be so important in modern medicine? Horseshoe crab blood is used to produce a substance called limulus amebocy

Lawyers for State wanted to use AIDS crisis to defend Ireland s ban on same-sex relationships

Global Medical Membranes Market Report 2022-2026: Developed

Transcripts for CNN CNN Newsroom Live 20211003 08:06:00

having me. it s welcome news. it s something akin to tamiflu that we ve used for quite a while in our armitarium for the flu. it is early days. it s a press release. we need to see the concrete data. more data needs to be revealed before we can really throw our confidence into it. but it would be a five-day course and it wouldn t really be for people who are so sick that they need to be admitted to the hospital. it would be for those who are testing positive and prevent them from being sick enough to be in the hospital and prevent mortality and death. it s really kind of hitting them in that antiviral phase, similar to rem desivir, although that s an intravenous drug, very expensive. we hope this will be cheap and effective. and it s very welcome news and we re hoping to have hopefully more than one of these types of medications in the future. so it would rely, then, on early detection and testing,

Transcripts for CNN CNN Newsroom Live 20211003 09:07:00

test and complaining of shortness of breath. thank you for having me. it s welcome news, something similar to tamiflu that we ve had for quite a while for the flu. it s a five-day course. it is early days. it s a press release. we do need to see the concrete data, more data needs to be revealed before we can really throw our confidence into it. but it would be a five-day course and it wouldn t really be for people who are so sick that they need to be admitted to the hospital. it would be for those who are testing positive and hit them early and prevent them from getting sick enough to be in the hospital and prevent mortality and death. it s really hitting them in that kind of antiviral phase, similar to remdesivir, although that s an intravenous drug, very expensive. we re hoping this is going to be cheap and effective and it s very welcome news and we re hoping to have hopefully more

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.